1-4 of 4
Ali R. Jazirehi, PhD
Close
Sort by
Journal Articles

Rituximab-Mediated Inhibition of the PI3K-Akt Survival Signaling Pathway in B-NHL Cell Lines Leading to Downregulation of Bclxl Expression and Chemosensitization.

Eriko Suzuki, Ali R. Jazirehi, PhD, Benjamin Bonavida, PhD
Journal: Blood
Blood (2005) 106 (11): 2830.
https://doi.org/10.1182/blood.V106.11.2830.2830
Published: 2005
Journal Articles

Chemosensitization of Drug-Resistant Ramos B-NHL to Drug-Induced Apoptosis: YY1 Expression Is Decreased in Response to Cytoskeletal-Interacting Drugs.

Mehran Neshat, PhD, Ali R. Jazirehi, PhD, Benjamin Bonavida, PhD
Journal: Blood
Blood (2005) 106 (11): 4806.
https://doi.org/10.1182/blood.V106.11.4806.4806
Published: 2005
Journal Articles

Regulation of Chemoresistance and Immune Resistance of B-NHL Cell Lines by Overexpression of YY1 and Bcl-xL, Respectively: Reversal of Resistance by Rituximab.

Mario I. Vega, PhD, Ali R. Jazirehi, PhD, Sara Huerta-Yepez, PhD, Benjamin Bonavida, PhD
Journal: Blood
Blood (2005) 106 (11): 1517.
https://doi.org/10.1182/blood.V106.11.1517.1517
Published: 2005
Journal Articles

Sensitization of Rituximab-Sensitive and Rituximab-Resistant B-NHL Cell Lines/Clones to TRAIL-Induced Apoptosis by Bortezomib and NF-κB Inhibitors.

Ali R. Jazirehi, PhD, Benjamin Bonavida, PhD
Journal: Blood
Blood (2005) 106 (11): 1514.
https://doi.org/10.1182/blood.V106.11.1514.1514
Published: 2005